Effects of celecoxib on ionic currents and spontaneous firing in rat retinal neurons

被引:18
作者
Frolov, R. V. [2 ]
Slaughter, M. M. [2 ,3 ]
Singh, S. [1 ,2 ]
机构
[1] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA
[2] SUNY Buffalo, Program Neurosci, Buffalo, NY 14214 USA
[3] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA
关键词
potassium channels; sodium channels; voltage-gated channels; electrophysiology; coxibs; pharmacology;
D O I
10.1016/j.neuroscience.2008.05.004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Accumulating evidence suggests that the side effects of celecoxib, widely used to treat muscle and joint pain, may be mediated in part through cyclooxygenase-2 (COX-2) independent mechanisms, such as inhibition of ion channels. In this study we report effects of celecoxib on ionic currents and neuronal activity in isolated rat retinal neurons. We found that celecoxib suppressed voltage-gated potassium currents in retinal bipolar cells with an effective concentration to inhibit 50% of function (EC50) of 5.5 mu M. In retinal amacrine and ganglion cells, celecoxib inhibited voltage-dependent sodium channels with an EC50 of 5.2 mu M, and voltage-dependent transient and sustained potassium currents with EC(50)s of 16.3 and 9.1 mu M, respectively. Notably, the rate of spontaneous spike activity was dramatically suppressed in ganglion and amacrine cells with an EC50 of 0.76 mu M. All actions of celecoxib on ionic currents and action potentials occurred from the extracellular side and were completely reversible. These findings indicate that inhibition of ion channels by celecoxib in the CNS may affect neuronal function at clinically relevant concentrations. (C) 2008 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1525 / 1532
页数:8
相关论文
共 23 条
  • [1] Celecoxib for the prevention of colorectal adenomatous polyps
    Arber, Nadir
    Eagle, Craig J.
    Spicak, Julius
    Racz, Istvan
    Dite, Petr
    Hajer, Jan
    Zavoral, Miroslav
    Lechuga, Maria J.
    Gerletti, Paola
    Tang, Jie
    Rosenstein, Rebecca B.
    Macdonald, Katie
    Bhadra, Pritha
    Fowler, Robert
    Wittes, Janet
    Zauber, Ann G.
    Solomon, Scott D.
    Levin, Bernard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (09) : 885 - 895
  • [2] Lesson of the week - Celecoxib, rofecoxib, and acute temporary visual impairment
    Coulter, DM
    Clark, DWJ
    Savage, RL
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7425): : 1214 - 1215
  • [3] Clinical pharmacokinetics and pharmacodynamics of celecoxib - A selective cyclo-oxygenase-2 inhibitor
    Davies, NM
    McLachlan, AJ
    Day, RO
    Williams, KM
    [J]. CLINICAL PHARMACOKINETICS, 2000, 38 (03) : 225 - 242
  • [4] Dual carbonic anhydrase -: Cyclooxygenase-2 inhibitors
    Dogne, Jean-Michel
    Thiry, Anne
    Pratico, Domenico
    Masereel, Bernard
    Supuran, Claudiu T.
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (09) : 885 - 891
  • [5] Feigenspan A, 1998, J NEUROSCI, V18, P6776
  • [6] The development of COX2 inhibitors
    Flower, RJ
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (03) : 179 - 191
  • [7] Ocular adverse effects associated with cyclooxygenase-2 inhibitors
    Fraunfelder, FW
    Solomon, J
    Mehelas, TJ
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2006, 124 (02) : 277 - 279
  • [8] Inhibition of delayed rectifier potassium channels and induction of arrhythmia
    Frolov, Roman V.
    Berim, Ilya G.
    Singh, Satpal
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (03) : 1518 - 1524
  • [9] Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study
    Graham, DJ
    Campen, D
    Hui, R
    Spence, M
    Cheetham, C
    Levy, G
    Shoor, S
    Graham, D
    [J]. LANCET, 2005, 365 (9458) : 475 - 481
  • [10] Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors
    Groesch, Sabine
    Maier, Thorsten Juergen
    Schiffmann, Susanne
    Geisslinger, Gerd
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (11): : 736 - 747